The New York Times
Alzheimer’s drug poses a dilemma for the FDA
Jason Karlawish of the Perelman School of Medicine commented on an Alzheimer’s medication, saying, “Physicians like me, who would be prescribers, are saying, ‘I want an effective drug to prescribe to my patients—but this is not the drug.’”
FULL STORY →